These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 15352931

  • 1. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
    Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R.
    Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
    [Abstract] [Full Text] [Related]

  • 2. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [Abstract] [Full Text] [Related]

  • 3. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 4. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 5. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ.
    Acta Psychiatr Scand Suppl; 2000 Oct 01; 400():17-22. PubMed ID: 10823307
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
    Genç Y, Taner E, Candansayar S.
    Adv Ther; 2007 Oct 01; 24(1):1-13. PubMed ID: 17526456
    [Abstract] [Full Text] [Related]

  • 7. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M, Knopf U, Henn FA, Thome J.
    Pharmacopsychiatry; 2004 Jan 01; 37(1):26-31. PubMed ID: 14750045
    [Abstract] [Full Text] [Related]

  • 8. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S, Katz G, Zislin Z, Knobler HY, Durst R.
    Acta Psychiatr Scand; 2000 Apr 01; 101(4):334-6. PubMed ID: 10782556
    [Abstract] [Full Text] [Related]

  • 9. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
    Psarros C, Theleritis CG, Paparrigopoulos TJ, Politis AM, Papadimitriou GN.
    Int J Geriatr Psychiatry; 2009 May 01; 24(5):518-22. PubMed ID: 19072747
    [Abstract] [Full Text] [Related]

  • 10. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P, Agelink MW, Naber D.
    Pharmacopsychiatry; 2005 Jan 01; 38(1):39-40. PubMed ID: 15706467
    [No Abstract] [Full Text] [Related]

  • 11. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R, Strous R, Bar F, Shaked G, Shiloh R, Rozencwaig S, Grupper D, Buchman N, Kotler M, Rabey JM, Weizman A.
    Hum Psychopharmacol; 2004 Jul 01; 19(5):343-6. PubMed ID: 15252826
    [Abstract] [Full Text] [Related]

  • 12. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM, Smith L.
    Acta Psychiatr Scand; 2009 Jun 01; 119(6):419-25. PubMed ID: 19245679
    [Abstract] [Full Text] [Related]

  • 13. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R, Salviati M, Fiorentini S, Biondi M.
    Exp Clin Psychopharmacol; 2007 Dec 01; 15(6):563-8. PubMed ID: 18179309
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M, Kuwilsky A, Krumm B, Dressing H.
    J Psychopharmacol; 2009 May 01; 23(3):305-14. PubMed ID: 18562423
    [Abstract] [Full Text] [Related]

  • 15. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR, Hounie AG, Sampaio AS, Arrais J, Miguel EC, Elkis H.
    Compr Psychiatry; 2009 May 01; 50(5):437-42. PubMed ID: 19683614
    [Abstract] [Full Text] [Related]

  • 16. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B, Hoogenboom G.
    Australas Psychiatry; 2004 Mar 01; 12(1):74-6. PubMed ID: 15715745
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK, Ungvari GS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May 01; 27(3):373-9. PubMed ID: 12691772
    [Abstract] [Full Text] [Related]

  • 18. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.
    Health Technol Assess; 2017 Sep 01; 21(49):1-56. PubMed ID: 28869006
    [Abstract] [Full Text] [Related]

  • 19. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I, Coudert AJ.
    Acta Psychiatr Belg; 1992 Sep 01; 92(6):323-38. PubMed ID: 1364281
    [Abstract] [Full Text] [Related]

  • 20. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A, Epshtein S, Sheinkman A, Tell E.
    Isr J Psychiatry Relat Sci; 2005 Sep 01; 42(1):61-3. PubMed ID: 16134408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.